October 29, 2024

(Reuters) -Pfizer raised its full-year profit forecast after better-than-expected sales of its COVID-19 treatment helped it beat Wall Street estimates for third-quarter earnings on Tuesday. Shares of the U.S. drugmaker rose 3.2% to $29.81 in premarket trading. Pfizer now expects annual profit to be in the range of $2.75 to $2.95 per share, compared to…

(Reuters) – JetBlue Airways forecast a bigger-than-expected fall in 2024 revenue amid a moderation in domestic travel demand ahead of the upcoming U.S. elections, sending its shares down 4.5% before the bell on Tuesday. Election-related uncertainty is expected to weigh on travel demand as consumers prefer to be home and hold off on major discretionary…